Does Medicare cover the Wegovy pill?

Yes. Both the Wegovy injection and the new Wegovy oral tablet qualify for Medicare's GLP-1 Bridge program at the same flat $50 monthly copay starting July 1, 2026. CMS treats them as equivalent for coverage purposes since both are Wegovy and both are FDA-approved for weight management.

Is the Wegovy pill as effective as the injection?

The injection produces somewhat greater weight loss in trials — about 15-17% body weight vs 12-14% for the tablet at one year. The injection's maximum dose is higher and absorption is more consistent. For most patients, both forms produce meaningful weight loss, but the injection is more potent.

How do you take the Wegovy tablet?

Take the tablet first thing in the morning with only a small amount of plain water (4 ounces or less), then wait at least 30 minutes before any food, drink, or other medications. The absorption enhancer in the tablet only works on an essentially empty stomach.

Are there other GLP-1 pills covered by Medicare for weight loss?

No. Wegovy is currently the only weight-loss GLP-1 available in tablet form. Rybelsus is a daily semaglutide tablet but is FDA-approved only for type 2 diabetes, not weight loss — so it is not covered under the Bridge for weight management. Other oral GLP-1 medications are in development but not yet approved.

Wegovy Pill vs Injection: What Medicare Covers

Q: Can I switch between the Wegovy pill and injection?

Yes. You can switch between forms if one is not working for you. Your prescriber will need to submit an updated prior authorization to CMS, but you are not locked into one form for the full Bridge demonstration period.

Two Forms of Wegovy

For years, Wegovy was only available as a weekly self-injection. In 2026, the FDA approved a new daily oral tablet form of Wegovy, also containing semaglutide. This is significant for seniors who have hesitated to start a GLP-1 because of needles — there is now a pill option.

Both forms qualify for Medicare's GLP-1 Bridge program at the same flat $50 monthly copay. But they are not identical medications, and the choice between them matters for effectiveness, side effects, and daily lifestyle.

Side-by-Side Comparison

Feature	Wegovy Injection	Wegovy Tablet
Active ingredient	Semaglutide	Semaglutide
How often taken	Once per week	Once per day
Route	Subcutaneous injection (under skin)	Oral pill
Doses available	0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg	Varies — lower max dose than injection
Maximum dose	2.4mg weekly	Lower (specific FDA-approved doses)
Avg. weight loss in trials	15-17% body weight	Approximately 12-14% body weight
Medicare Bridge eligible	Yes — $50/month	Yes — $50/month
Food restrictions	None	Yes — must take on empty stomach
Storage	Refrigerated	Room temperature

How the Tablet Works Differently

The oral tablet uses a special absorption enhancer (SNAC — sodium N-(8-[2-hydroxybenzoyl] amino) caprylate) that helps semaglutide survive stomach acid and get absorbed through the stomach lining. This was a major pharmaceutical engineering achievement — peptide drugs like semaglutide are normally destroyed by digestion.

The catch: the absorption enhancer only works if your stomach is essentially empty. This means:

Take the tablet first thing in the morning
With only a small amount of plain water (4 ounces or less)
No food, drink, or other medications for at least 30 minutes after taking it

This is a meaningful daily commitment. If you regularly take morning medications with food or coffee, you will need to rearrange your routine to fit Wegovy tablets.

Effectiveness Differences

Clinical trials show the injection produces somewhat greater weight loss than the tablet — about 15-17% body weight vs 12-14% at one year. Why the gap?

Dose ceiling — The injection's maximum 2.4mg dose is higher than the oral form's approved maximum
Absorption variability — Oral absorption depends on stomach conditions, hydration, and timing; injection delivers a consistent dose
Adherence — Daily pill regimens have lower long-term adherence than weekly injections in general

In practical terms: most patients lose meaningful weight on either form, but the injection is more potent.

Side Effect Differences

The side effect profiles are similar — both forms cause nausea, constipation, and the other GLP-1 GI effects. Differences worth noting:

Tablet:

Slightly higher nausea rates in some studies, particularly during the first weeks
More variable day-to-day side effects (depending on whether the timing/water rules were followed)
No injection site reactions

Injection:

Once-weekly cadence — side effects often peak 12-48 hours after injection and improve through the week
Injection site reactions (mild redness, itching) in some patients
More predictable, steady-state symptoms

For comprehensive side effect management, see our GLP-1 Side Effects in Seniors guide.

Which Should Seniors Choose?

There is no universally "better" choice — the right answer depends on your priorities:

Choose the Tablet If:

You have strong needle anxiety
You travel frequently and want simpler storage (no refrigeration)
You already have a strict morning routine that can accommodate the timing rules
You prefer daily small actions over weekly larger ones

Choose the Injection If:

You want maximum weight-loss effect
You take multiple morning medications with food or coffee
You prefer a once-a-week commitment over daily attention
You have stable refrigerator access

Talk to Your Doctor About:

Your current morning routine and medications
Any history of GI conditions that affect absorption (gastroparesis, post-bariatric anatomy)
Whether you have refrigerator space and stability for the injection
Your hand dexterity (the injection pen is designed for ease but still requires manipulation)

Medicare Coverage — Both Forms Qualify

Under the GLP-1 Bridge program (starting July 1, 2026), both the injection and the tablet are covered at the same $50 monthly copay. CMS treats them as equivalent for coverage purposes — both are Wegovy, both are FDA-approved for weight management.

You can also switch between forms if one is not working for you, though your prescriber will need to submit an updated prior authorization. The Bridge does not lock you into one form for the full demonstration.

For details on the Bridge, eligibility tiers, and what to bring to your doctor, see our Medicare & GLP-1 coverage guide. Not sure if you qualify? Take the 2-minute eligibility quiz.

What About Other GLP-1 Pills?

Currently, Wegovy is the only weight-loss GLP-1 available in tablet form. Rybelsus is a daily semaglutide tablet, but it is FDA-approved for type 2 diabetes, not weight loss — so it is not covered under the Bridge.

Other potential oral GLP-1 medications are in clinical development (Eli Lilly's orforglipron, others), but none are FDA-approved or Medicare-covered yet as of 2026.

The Bottom Line

If injections are the only thing keeping you from trying a GLP-1, the new Wegovy tablet is a real, FDA-approved option — and Medicare covers it at the same $50 Bridge copay as the injection. It is somewhat less potent and requires careful daily timing, but for needle-averse seniors, that may be a worthwhile trade-off.

For most people without needle anxiety, the weekly injection is still the more effective and simpler option.

Find a Prescriber

Use our Provider Directory to find Medicare-friendly GLP-1 prescribers in your state.

Track Your Progress

Whether you choose the pill or injection, the free CairnSpace tracker helps you log daily protein, hydration, symptoms, and weight — built specifically for people on GLP-1 medications. No sign-up fees, no ads.